| Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for … C Magnussen, TJ Niiranen, FM Ojeda, F Gianfagna, S Blankenberg, ... Circulation 136 (17), 1588-1597, 2017 | 470 | 2017 |
| Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature D Reichart, C Magnussen, T Zeller, S Blankenberg Journal of internal medicine 286 (4), 362-372, 2019 | 174 | 2019 |
| Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme EL Petersen, A Goßling, G Adam, M Aepfelbacher, CA Behrendt, E Cavus, ... European Heart Journal 43 (11), 1124-1137, 2022 | 157 | 2022 |
| Early rhythm control therapy in patients with atrial fibrillation and heart failure A Rillig, C Magnussen, AK Ozga, A Suling, A Brandes, G Breithardt, ... Circulation 144 (11), 845-858, 2021 | 157 | 2021 |
| Biomarkers for heart failure: small molecules with high clinical relevance C Magnussen, S Blankenberg Journal of internal medicine 283 (6), 530-543, 2018 | 134 | 2018 |
| Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes D Csengeri, NA Sprünker, A Di Castelnuovo, T Niiranen, ... European heart journal 42 (12), 1170-1177, 2021 | 111 | 2021 |
| Gender differences and outcomes in left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support C Magnussen, AM Bernhardt, FM Ojeda, FM Wagner, J Gummert, ... The Journal of Heart and Lung Transplantation 37 (1), 61-70, 2018 | 107 | 2018 |
| Sex-specific epidemiology of heart failure risk and mortality in Europe: results from the BiomarCaRE Consortium C Magnussen, TJ Niiranen, FM Ojeda, F Gianfagna, S Blankenberg, ... JACC: Heart Failure 7 (3), 204-213, 2019 | 92 | 2019 |
| Temporal trends in incidence and outcome of acute coronary syndrome JT Neumann, A Goßling, NA Sörensen, S Blankenberg, C Magnussen, ... Clinical Research in Cardiology 109, 1186-1192, 2020 | 81 | 2020 |
| Relations of sex to diagnosis and outcomes in acute coronary syndrome NA Sörensen, JT Neumann, F Ojeda, S Schäfer, C Magnussen, T Keller, ... Journal of the American Heart Association 7 (6), e007297, 2018 | 50 | 2018 |
| FEV1 and FVC predict all-cause mortality independent of cardiac function—Results from the population-based Gutenberg Health Study C Magnussen, FM Ojeda, N Rzayeva, T Zeller, CR Sinning, N Pfeiffer, ... International journal of cardiology 234, 64-68, 2017 | 48 | 2017 |
| High-sensitivity cardiac troponin I levels and prediction of heart failure: results from the BiomarCaRE consortium I Yan, CS Börschel, JT Neumann, NA Sprünker, N Makarova, J Kontto, ... Heart Failure 8 (5), 401-411, 2020 | 45 | 2020 |
| High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study B Waschki, P Alter, T Zeller, C Magnussen, JT Neumann, R Twerenbold, ... European Respiratory Journal 55 (2), 2020 | 34 | 2020 |
| Applying the ESC 2016, H2FPEF, and HFA‐PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population J Nikorowitsch, R Bei der Kellen, P Kirchhof, C Magnussen, A Jagodzinski, ... ESC Heart Failure 8 (5), 3603-3612, 2021 | 27 | 2021 |
| Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality S Camen, FM Ojeda, T Niiranen, F Gianfagna, JK Vishram-Nielsen, ... EP Europace 22 (4), 522-529, 2020 | 24 | 2020 |
| Sex differences in patients with cardiogenic shock I Yan, B Schrage, J Weimann, S Dabboura, R Hilal, BN Beer, PM Becher, ... ESC Heart Failure 8 (3), 1775-1783, 2021 | 22 | 2021 |
| Prediction of heart transplant rejection from routine pathology slides with self-supervised deep learning TP Seraphin, M Luedde, C Roderburg, M van Treeck, P Scheider, ... European Heart Journal-Digital Health 4 (3), 265-274, 2023 | 19 | 2023 |
| CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy L Keil, C Chevalier, P Kirchhof, S Blankenberg, G Lund, K Müllerleile, ... International Journal of Molecular Sciences 22 (13), 7115, 2021 | 17 | 2021 |
| Metabolic communication by SGLT2 inhibition AM Billing, YC Kim, S Gullaksen, B Schrage, J Raabe, A Hutzfeldt, ... Circulation 149 (11), 860-884, 2024 | 16 | 2024 |
| Right heart failure before LVAD implantation predicts right heart failure after LVAD implantation–is it that easy? T Wagner, AM Bernhardt, C Magnussen, H Reichenspurner, ... Journal of Cardiothoracic Surgery 15, 1-9, 2020 | 16 | 2020 |
